Research Proposal Template Qualitative

INSTITUTIONAL RESEARCH PROPOSAL AND SERVICES AGREEMENT

Document ID: IRPSA-QL-202X-V1
Effective Date: [Effective Date]
Version: 1.0
Governing Jurisdiction: State of [State] / Federal Laws of the United States

---

1. STATUTORY & LEGAL COMPLIANCE NOTICE

CRITICAL LEGAL NOTICE: This document constitutes a binding legal agreement governing the provision of qualitative research services. The terms, conditions, and operational frameworks set forth herein have been drafted to ensure legal enforceability across commercial, academic, and institutional jurisdictions within the United States. Parties acknowledge that qualitative research methodologies involving human subjects may be subject to institutional review board (IRB) oversight, data privacy statutes (including but not limited to the California Consumer Privacy Act (CCPA), the General Data Protection Regulation (GDPR) where applicable, and industry-specific confidentiality mandates). Execution of this Agreement binds all parties to strict compliance with applicable statutory frameworks. Legal counsel should be consulted to verify localized compliance requirements prior to execution.

---

2. PARTIES & RECITALS

This Research Proposal and Services Agreement (the "Agreement") is entered into and made effective as of [Effective Date] (the "Effective Date"), by and between:

[Company Full Legal Name], a [State of Incorporation] [Corporation/LLC], having its principal place of business located at [Principal Address] (hereinafter referred to as the "Research Provider"), and

[Client Full Legal Name], a [State of Incorporation] [Corporation/LLC], having its principal place of business located at [Principal Address] (hereinafter referred to as the "Client").

RECITALS

WHEREAS, the Client desires to engage the Research Provider to design, execute, and deliver a comprehensive qualitative research study, and the Research Provider possesses the requisite expertise, personnel, and operational infrastructure to perform such services; and

WHEREAS, the parties intend to set forth the terms and conditions governing the scope of work, financial compensation, intellectual property rights, data handling, and legal liabilities associated with the research engagement;

NOW, THEREFORE, in consideration of the mutual covenants, promises, and obligations contained herein, and intending to be legally bound hereby, the parties agree as follows:

---

3. EXHAUSTIVE OPERATIVE CLAUSES & LEGAL TERMS

SECTION 1: SCOPE OF SERVICES & ENGAGEMENT

1.1 Engagement of Services. The Client hereby retains the Research Provider, and the Research Provider accepts such retention, to perform the qualitative research services outlined in the Statement of Work (SOW) attached hereto as Exhibit A and incorporated herein by this reference (the "Services"). 1.2 Methodology and Execution. The Research Provider shall execute the Services utilizing recognized qualitative research methodologies, including but not limited to semi-structured interviews, focus groups, ethnographic observations, and thematic content analysis, as specified in Exhibit A. The Research Provider shall maintain absolute professional independence in the execution of the research design while remaining responsive to the strategic objectives articulated by the Client. 1.3 Deliverables. The Research Provider shall deliver the final qualitative research report, raw anonymized transcripts, coding frameworks, and associated analytical assets (collectively, the "Deliverables") in accordance with the delivery schedule set forth in Exhibit A. 1.4 Changes to Scope. Any material modification, expansion, or reduction of the Services must be formalized through a written Change Order signed by authorized representatives of both parties, detailing any corresponding adjustments to fees, timelines, and deliverables.

SECTION 2: COMPENSATION & PAYMENT TERMS

2.1 Total Compensation. In consideration for the full and faithful performance of the Services, the Client shall pay to the Research Provider the total sum of [Amount in USD] USD (the "Contract Price"), payable in accordance with the milestone schedule set forth in Exhibit B. 2.2 Invoicing. The Research Provider shall issue formal invoices to the Client upon the completion of each respective milestone or billing interval as specified in Exhibit B. 2.3 Payment Terms. All invoices are due and payable within thirty (30) calendar days from the date of receipt by the Client (Net 30). Payments shall be remitted via wire transfer, ACH, or check in United States Dollars to the bank account designated in writing by the Research Provider. 2.4 Late Payment Interest. Any undisputed amount not paid when due shall accrue interest at the lesser of one and one-half percent (1.5%) per month or the maximum rate permitted by applicable law, calculated from the date such payment was due until the date of actual payment. 2.5 Expenses. Unless otherwise expressly provided in Exhibit B, the Contract Price includes all standard operational, travel, and administrative expenses incurred by the Research Provider. Pre-approved extraordinary out-of-pocket expenses shall be reimbursed by the Client at actual cost, subject to the presentation of valid receipts and prior written authorization. 2.6 Taxes. The Contract Price is exclusive of all applicable federal, state, and local sales, use, value-added, or excise taxes. The Client shall be solely responsible for the payment of all such taxes, excluding taxes based solely on the net income of the Research Provider.

SECTION 3: TERM & TERMINATION

3.1 Term. This Agreement shall commence on the Effective Date and shall continue in full force and effect until the complete delivery and acceptance of all Services and Deliverables, or until terminated earlier in accordance with the provisions of this Section 3 (the "Term"). 3.2 Termination for Convenience. The Client may terminate this Agreement, in whole or in part, at any time for any reason or no reason, by providing thirty (30) calendar days prior written notice to the Research Provider. Upon receipt of such notice, the Research Provider shall immediately cease performance, mitigate ongoing expenses, and compile all completed and in-progress Deliverables. 3.3 Termination for Cause. Either party may terminate this Agreement immediately upon written notice if the other party materially breaches any of its obligations hereunder and fails to cure such material breach within fifteen (15) calendar days following receipt of written notice detailing the specific breach. 3.4 Effect of Termination. Upon termination of this Agreement for any reason:

• (a) The Client shall promptly pay the Research Provider for all Services performed and non-cancellable commitments incurred up to the effective date of termination, calculated on a pro-rata basis against the milestone schedule.
• (b) Each party shall promptly return or securely destroy all Confidential Information of the other party in its possession, subject to standard archival retention policies required by law or institutional compliance.

SECTION 4: INTELLECTUAL PROPERTY OWNERSHIP & WORK MADE FOR HIRE

4.1 Work Made for Hire. To the maximum extent permitted by applicable law, all custom qualitative research reports, final presentations, and synthesized analytical insights specifically generated by the Research Provider for the Client under this Agreement shall be deemed "Works Made for Hire" (as defined under Section 101 of the United States Copyright Act). 4.2 Assignment of Rights. To the extent that any Deliverable does not qualify as a Work Made for Hire, the Research Provider hereby irrevocably assigns, transfers, and conveys to the Client all right, title, and interest worldwide in and to such Deliverable, including all copyrights, trademarks, trade secrets, and other intellectual property rights therein, upon receipt of full and final payment of the Contract Price. 4.3 Research Provider Background IP & Methodologies. Notwithstanding anything to the contrary herein, the Research Provider retains all right, title, and interest in and to its pre-existing proprietary methodologies, research frameworks, analytical tools, software, templates, general know-how, and generic industry insights (collectively, "Background IP"). To the extent that any Deliverable incorporates Background IP, the Research Provider grants the Client a perpetual, irrevocable, worldwide, non-exclusive, royalty-free license to use, reproduce, and internalize such Background IP solely as embedded within the Deliverables. 4.4 Participant Anonymity and Data Rights. The Research Provider retains ownership of raw field notes, audio/video recordings, and verbatim transcripts containing Personally Identifiable Information (PII) of research participants, subject to strict adherence to participant confidentiality commitments, institutional ethics approvals, and applicable data privacy regulations.

SECTION 5: MUTUAL CONFIDENTIALITY & NON-DISCLOSURE

5.1 Definition of Confidential Information. "Confidential Information" means all non-public, proprietary, or confidential information disclosed by one party (the "Disclosing Party") to the other party (the "Receiving Party"), whether orally or in written, electronic, or other form, that is designated as confidential or that reasonably should be understood to be confidential given the nature of the information and the circumstances of disclosure, including business plans, customer lists, research methodologies, pricing, trade secrets, and participant data. 5.2 Obligations of Non-Disclosure. The Receiving Party shall:

• (a) Protect the Disclosing Party's Confidential Information with the same degree of care it uses for its own confidential information, but no less than a reasonable standard of care;
• (b) Not disclose the Confidential Information to any third party, except to its directors, officers, employees, legal counsel, and contractors who need to know such information for the performance of this Agreement and who are bound by confidentiality obligations at least as restrictive as those contained herein; and
• (c) Use the Confidential Information solely for the purpose of performing its obligations or exercising its rights under this Agreement. 5.3 Exclusions. Confidential Information shall not include information that:
• (a) Is or becomes generally known to the public through no breach of this Agreement by the Receiving Party;
• (b) Was already known to the Receiving Party prior to disclosure without an obligation of confidentiality;
• (c) Is independently developed by the Receiving Party without reference to or use of the Disclosing Party's Confidential Information; or
• (d) Is required to be disclosed by law, regulation, or court order, provided the Receiving Party gives prompt written notice to the Disclosing Party to enable the Disclosing Party to seek a protective order.

SECTION 6: REPRESENTATIONS & WARRANTIES

6.1 Research Provider Representations. The Research Provider represents and warrants that:

• (a) It is duly organized, validly existing, and in good standing under the laws of its jurisdiction of incorporation;
• (b) It has the full power and authority to enter into this Agreement and perform the Services;
• (c) The Services will be performed in a professional, workmanlike manner, in accordance with industry standards and professional ethics; and
• (d) The Deliverables created by the Research Provider will not infringe upon or misappropriate the intellectual property rights of any third party. 6.2 Client Representations. The Client represents and warrants that:
• (a) It is duly organized, validly existing, and in good standing under the laws of its jurisdiction of incorporation;
• (b) It has the full power and authority to enter into this Agreement and fulfill its financial and operational obligations; and
• (c) Any data, materials, or background documentation provided to the Research Provider for use in the Services do not violate any third-party rights or applicable laws. 6.3 Disclaimer of Implied Warranties. EXCEPT AS EXPRESSLY SET FORTH IN THIS SECTION 6, THE RESEARCH PROVIDER MAKES NO OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NONINFRINGEMENT. QUALICATIVE RESEARCH INSIGHTS ARE BASED ON ANALYTICAL INTERPRETATIONS OF SAMPLE POPULATIONS AND DO NOT CONSTITUTE GUARANTEES OF COMMERCIAL SUCCESS OR SPECIFIC MARKET OUTCOMES.

SECTION 7: LIMITATION OF LIABILITY & INDEMNIFICATION

7.1 Limitation of Liability. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, PUNITIVE, OR EXEMPLARY DAMAGES, INCLUDING LOSS OF PROFITS, LOSS OF REVENUE, LOSS OF DATA, OR BUSINESS INTERRUPTION, ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, REGARDLESS OF THE THEORY OF LIABILITY (CONTRACT, TORT, NEGLIGENCE, STRICT LIABILITY, OR OTHERWISE), EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 7.2 Cap on Liability. THE AGGREGATE LIABILITY OF EITHER PARTY ARISING OUT OF OR RELATING TO THIS AGREEMENT, WHETHER IN CONTRACT, TORT, OR OTHERWISE, SHALL BE STRICTLY LIMITED TO THE TOTAL AMOUNT ACTUALLY PAID BY THE CLIENT TO THE RESEARCH PROVIDER UNDER THIS AGREEMENT IN THE TWELVE (12) MONTHS PRECEDING THE EVENT GIVING RISE TO LIABILITY. 7.3 Indemnification by Research Provider. The Research Provider agrees to defend, indemnify, and hold harmless the Client, its officers, directors, and employees from and against any third-party claims, liabilities, losses, damages, and reasonable attorney's fees arising out of or resulting from:

• (a) The Research Provider's gross negligence or willful misconduct in the performance of the Services; or
• (b) Any allegation that the Deliverables infringe or misappropriate any valid third-party intellectual property right. 7.4 Indemnification by Client. The Client agrees to defend, indemnify, and hold harmless the Research Provider, its officers, directors, and employees from and against any third-party claims, liabilities, losses, damages, and reasonable attorney's fees arising out of or resulting from:
• (a) The Client's breach of its representations, warranties, or obligations under this Agreement; or
• (b) The Research Provider's authorized use of materials, data, or intellectual property provided by the Client.

SECTION 8: DISPUTE RESOLUTION & ARBITRATION

8.1 Good Faith Negotiations. In the event of any dispute, controversy, or claim arising out of or relating to this Agreement, the parties shall first attempt in good faith to resolve such dispute through senior management negotiations for a period of thirty (30) calendar days from receipt of written notice of dispute. 8.2 Binding Arbitration. If the dispute is not resolved through good faith negotiations within thirty (30) calendar days, the dispute shall be submitted to final and binding arbitration administered by the American Arbitration Association (AAA) in accordance with its Commercial Arbitration Rules. The place of arbitration shall be [City, State]. The arbitration shall be conducted by a single neutral arbitrator appointed in accordance with AAA rules. The award rendered by the arbitrator shall be final, binding, and enforceable in any court of competent jurisdiction. 8.3 Injunctive Relief. Nothing in this Section 8 shall prevent either party from seeking preliminary injunctive relief or other equitable remedies from a court of competent jurisdiction with respect to any breach of intellectual property rights or confidentiality obligations.

SECTION 9: GOVERNING LAW & JURISDICTION

9.1 Governing Law. This Agreement, and all claims or causes of action (whether in contract, tort, or statute) that may be based upon, arise out of, or relate to this Agreement, shall be governed by, enforced under, and construed in accordance with the internal laws of the State of [State], without regard to its conflict of laws principles. 9.2 Jurisdiction. Subject to Section 8, each party irrevocably and unconditionally submits to the exclusive personal jurisdiction of the state and federal courts located in [County], [State], for any legal action or proceeding arising out of this Agreement.

SECTION 10: MISCELLANEOUS

10.1 Severability. If any provision of this Agreement is held to be invalid, illegal, or unenforceable by a court of competent jurisdiction, such provision shall be modified to the minimum extent necessary to make it valid and enforceable, and the remaining provisions shall remain in full force and effect. 10.2 Counterparts & Electronic Signatures. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of an executed counterpart of this Agreement by facsimile, email PDF, or digital signature platform (such as DocuSign or Adobe Sign) shall be equally effective as delivery of an original executed copy. 10.3 Entire Agreement. This Agreement, including all Exhibits attached hereto, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous discussions, negotiations, proposals, understandings, and agreements, whether written or oral. 10.4 Waiver. No waiver of any breach of any provision of this Agreement shall constitute a waiver of any prior, concurrent, or subsequent breach of the same or any other provision hereof. 10.5 Force Majeure. Neither party shall be liable for any failure or delay in performing its obligations under this Agreement if such failure or delay is caused by acts of God, natural disasters, war, terrorism, civil unrest, labor strikes, pandemics, governmental regulations, or other causes beyond the reasonable control of the affected party. 10.6 Assignment. Neither party may assign, delegate, or transfer this Agreement or any of its rights or obligations hereunder, whether voluntarily or by operation of law, without the prior written consent of the other party; provided, however, that either party may assign this Agreement without consent to a successor in interest resulting from a merger, acquisition, or sale of all or substantially all of its assets.

---

4. EXHIBIT A: STATEMENT OF WORK (SOW)

1. Project Title: Qualitative Research Engagement: [Project Name]
2. Project Objectives: To investigate consumer/stakeholder perceptions regarding [Topic/Domain] through rigorous qualitative data collection and thematic synthesis.
3. Methodology:

• Recruitment of [Number] qualified participants meeting specific screening criteria.
• Conduct of [Number] semi-structured depth interviews or focus groups.
• Verbatim audio transcription and qualitative coding via [Coding Software/Methodology].
  4. Project Timeline:
• Phase 1 (Setup & Screener Development): Weeks 1–2
• Phase 2 (Data Collection & Fieldwork): Weeks 3–6
• Phase 3 (Analysis & Report Drafting): Weeks 7–8
• Phase 4 (Final Presentation & Delivery): Week 9

---

5. EXHIBIT B: COMPENSATION & MILESTONE SCHEDULE

• Milestone 1: Execution of Agreement & SOW Approval (30%): $[Amount]
• Milestone 2: Completion of Fieldwork & Transcript Delivery (40%): $[Amount]
• Milestone 3: Delivery and Acceptance of Final Research Report (30%): $[Amount]
• Total Contract Price: [Amount in USD]

---

6. EXECUTION & FORMAL SIGNATURE BLOCKS

IN WITNESS WHEREOF, the parties hereto have caused this Research Proposal and Services Agreement to be duly executed by their respective authorized signatories as of the Effective Date written above.

FOR [COMPANY FULL LEGAL NAME] (RESEARCH PROVIDER):

Signature: _____________________________________
Printed Name: [Authorized Signatory Name]
Title: [Title / Role]
Company: [Company Legal Name]
Date: [Date]

FOR [CLIENT FULL LEGAL NAME] (CLIENT):

Signature: _____________________________________
Printed Name: [Authorized Signatory Name]
Title: [Title / Role]
Company: [Client Full Legal Name]
Date: [Date]

---

7. STEP-BY-STEP EXECUTION & FILING GUIDE

1. Document Preparation: Copy and paste the entire Markdown text into Microsoft Word or Google Docs. Utilize the Find & Replace function to populate all bracketed fields (e.g., replace [Company Full Legal Name] with the exact legal entity name).
2. Review & Customization: Ensure Exhibits A and B accurately reflect the negotiated research scope, participant quotas, timelines, and fee structures. Legal counsel should verify that the governing jurisdiction aligns with corporate domicile or operational preference.
3. Signatory Verification: Confirm that the individuals signing on behalf of both entities possess actual or apparent corporate authority to bind their respective organizations (e.g., CEO, Managing Director, Authorized Officer).
4. Digital Execution: Upload the finalized document into an enterprise electronic signature platform (such as DocuSign, Adobe Sign, or HelloSign). Configure signing routing to capture signatures from both parties sequentially or simultaneously.
5. Post-Execution Filing & Archiving: Upon full execution, download the finalized PDF containing the cryptographic audit trail/certificate of completion. Store the executed agreement in the corporate contract repository under secure, access-controlled directory structures in compliance with corporate document retention policies.